Walmart settles $50 million opioid case over prescription compliance failures
Walmart settles $50M for illegal opioid prescription filling and inadequate DEA reporting.
Event / Security
Walmart Opioid Settlement
Walmart agreed to pay $50 million to settle federal allegations that its pharmacies illegally filled thousands of invalid opioid prescriptions from 2013 onward, with compliance violations and inadequate DEA reporting.
2 reported locations
Daily activity
1 articles0 articles
2026-08-30 to 2026-11-07 · UTC publication dates
Coverage begins 30 Aug, 02:50 UTC
Follow the documented timeline or explore the related reporting.
What happened
Walmart reported minimal suspicious orders to DEA despite massive opioid shipments
Over approximately a four-year period, Walmart shipped an estimated 37.5 million controlled-substance orders to its pharmacies but reported only 204 suspicious orders to the Drug Enforcement Administration. This represented a failure to detect and report suspicious orders as required by law.
Walmart pharmacists knowingly filled prescriptions with obvious red flags
Walmart pharmacists allegedly filled prescriptions they knew were invalid, including dangerous combinations of opioids and non-opioids, excessively repeated fills of high-dosage opioids, and repeated requests for early refills of controlled substances. Some pharmacists filled prescriptions for large doses that could have killed a patient. Pharmacists in Florida alerted the company's compliance unit about a doctor operating as a 'pill mill' and filled more than 3,500 controlled-substance prescriptions for that doctor.
Walmart compliance team prioritized sales over controlled substance regulations
Walmart's compliance team, aware that certain prescribers were operating as 'pill mills,' continued to fill prescriptions from those prescribers. When Walmart pharmacists reported suspected illegal activity through thousands of 'refusal-to-fill' forms, the compliance team viewed driving sales and patient awareness as a better use of their time than analyzing the refusal reports. This prioritization of sales over compliance with the Controlled Substances Act was acknowledged by a director on the compliance team in internal emails.
Opioid overdoses killed approximately 806,000 Americans from 1999 to 2023
From 1999 to 2023, approximately 806,000 people died from opioid overdoses in the United States, including deaths involving both illegal and prescription opioids, according to the Centers for Disease Control and Prevention.
Walmart required to establish hotline and monitoring systems for controlled substance dispensing
As part of the settlement, Walmart entered into a memorandum of agreement with the DEA requiring the company to establish a hotline for employees and patients to report suspected illegal dispensing of controlled substances, proactively monitor pharmacy dispensing patterns to identify and address potential violations, and implement a process to evaluate prescribers suspected of illegal prescribing.
Walmart agrees to $50 million settlement over illegal opioid prescription filling
Walmart agreed to pay $50 million to settle allegations that its pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act. The settlement was announced by the U.S. Justice Department and Drug Enforcement Administration. The government complaint, originally filed in December 2020 and amended in 2022, alleged that since June 2013, Walmart filled invalid prescriptions through the knowing actions of individuals on its compliance team and pharmacists.
Read the coverage
2 alternative perspectives